
Chinese pharmaceutical company founded on 28 January 2000 at the foot of Mount Mogan in Deqing county, Huzhou, Zhejiang, and listed on the Shenzhen ChiNext board on 22 February 2011 under code 300181. A national high-tech modern pharmaceutical enterprise integrating research, manufacturing and sales across a 260 mu site with more than 150,000 square metres of buildings. Its main products are Wuling capsules, Lingze tablets, Lianhua granules, Bailing tablets and capsules, notoginseng powder, fritillaria powder, ganoderma spore powder, calcium polycarbophil tablets and granules and multi-trace element injections.
Leave your rating